HCM

NASDAQ HEALTHCARE

HUTCHMED DRC

$11.15

$0.03 (+0.27%)

Live quote

52w: $9.77 – $19.50

Loading chart…

P/E Ratio21.23

P/B Ratio7.84

EV/EBITDA—

Debt/Equity—

ROE36.91%

ROIC—

Revenue Growth-12.96%

Gross Margin—

HUTCHMED (China) Limited discovers, develops and markets targeted immunotherapies and therapies for cancer and immune diseases globally. The company is headquartered in Central, Hong Kong.

Own HCM? Track it here.

Create a free account to add HCM to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account